---
title: Pharmaron vs WuXi AppTec
slug_a: pharmaron
slug_b: wuxiapptec
site: cro
review_signal_gate: closed
canonical_path: /compare/pharmaron/wuxiapptec
generated_by: BioBM Editorial AI
---

# Pharmaron vs WuXi AppTec

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Pharmaron (pharmaron) is listed for both. Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.

Services: 99. Modalities: 14. Indications: 14. Locations: 32. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (99).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

WuXi AppTec (wuxiapptec) is listed for cro. Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.

Services: 41. Modalities: 10. Indications: 14. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (41).

Review summary: Review summary withheld until site-level review gate opens.